MELD, MELD-Na and MELD 3.0 Calculator


Compute the Model for End-Stage Liver Disease score in its original, sodium-adjusted and 2023 (MELD 3.0) versions.

Enter the values and click Calculate.

Enter your values:
mmol/L
Results:

About this calculator

MELD estimates three-month mortality in chronic liver disease and has been used to rank people for liver transplant. MELD-Na added sodium in 2016. MELD 3.0 added sex and albumin and replaced MELD-Na in United States liver allocation in July 2023.

What you need

  • Total bilirubin in mg/dL or micromol/L.
  • INR, not raised by anticoagulants.
  • Serum creatinine in mg/dL or micromol/L. If the patient had dialysis at least twice in the past week, the calculation uses creatinine 4.0 mg/dL for legacy MELD and MELD-Na, and 3.0 mg/dL for MELD 3.0 under OPTN policy. Select Yes for dialysis; other required laboratory values must still be entered.
  • Serum sodium in mmol/L, needed for MELD-Na and MELD 3.0; typical is 135 to 145.
  • Serum albumin in g/dL or g/L, and sex, both used only by MELD 3.0.

Formula

MELD(i) = 0.957 x ln(creatinine) + 0.378 x ln(bilirubin) + 1.120 x ln(INR) + 0.643, multiplied by 10 and rounded.

MELD-Na = MELD(i) + 1.32 x (137 - Na) - 0.033 x MELD(i) x (137 - Na), applied when MELD(i) is above 11.

MELD 3.0 = 1.33 (if female) + 4.56 ln(bilirubin) + 0.82 (137 - Na) - 0.24 (137 - Na) ln(bilirubin) + 9.09 ln(INR) + 11.14 ln(creatinine) + 1.85 (3.5 - albumin) - 1.83 (3.5 - albumin) ln(creatinine) + 6.

How to read the result

Higher means sicker: each version estimates three-month mortality in chronic liver disease, and transplant allocation uses the current policy score, MELD 3.0 in the United States since July 2023. As rough orientation, scores under 10 carry low short-term mortality while scores of 30 or more carry high mortality and priority for transplant evaluation. The three versions usually sit close together; when they disagree, the allocation policy's version is the one that counts.

Worked example

Creatinine 2.0, bilirubin 3.0, INR 1.5: MELD = 22. With sodium 130, MELD-Na = 26. With albumin 3.0 and male sex, MELD 3.0 = 27.

Common mistakes

  • Forgetting the dialysis setting: dialysis at least twice in the past week uses creatinine 4.0 mg/dL for MELD/MELD-Na and 3.0 mg/dL for MELD 3.0.
  • Using the score in acute liver failure or in children under 12, where it is not validated.
  • Reading an INR raised by warfarin as liver dysfunction.
  • Treating the output as the allocation score without checking current OPTN caps and exception rules.

Limitations

Exceptions, rounding details and caps are set by OPTN policy and can change; check the current policy when the score is used for allocation. The score is not validated in acute liver failure, children under 12 (PELD is used), or when INR is raised by anticoagulants.

Frequently asked questions

Which of the three scores should I quote?

For transplant allocation in the US, MELD 3.0 per current policy. MELD-Na still appears in much of the literature, and the original MELD remains in older drug and trial criteria.

Why did MELD 3.0 add sex and albumin?

Women's lower creatinine for the same kidney function had systematically under-scored them, and albumin carried independent prognostic information; refitting with both improved waiting-list mortality prediction.

Reference

  • Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33(2):464-470.
  • Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008;359:1018-1026.
  • Kim WR, Mannalithara A, Heimbach JK, et al. MELD 3.0: the Model for End-Stage Liver Disease updated for the modern era. Gastroenterology 2021;161(6):1887-1895. doi:10.1053/j.gastro.2021.08.050

Disclaimer. Medical information only. This calculator is an educational aid for clinicians and students. It does not give medical advice, diagnosis or treatment, and it does not replace clinical judgment. Check results against the original source and local protocols before using them in patient care.